Dr. Ioannis A. Ieropoulos
Bristol Robotics Laboratory, England
 
Abstract
      
      
      
      
      
      The development of the microbial fuel cell (MFC)
        technology has seen an enormous growth over the last hundred
        years since its inception by Potter in 1911. The highest level
        of activity has been recorded over the last decade and it is
        perhaps considered commonplace that MFCs are primarily suitable
        for stationary, passive wastewater treatment applications.
        Sceptics have certainly not considered MFCs as serious
        contenders in the race for developing renewable energy
        technologies. Yet this is the only type of alternative system
        that can convert organic waste—widely distributed around the
        globe—directly into electricity, and therefore, the only
        technology that will allow artificial agents to autonomously
        operate in a plethora of environments. This talk will focus on
        the implementation of MFCs in real life practical applications
        and furthermore, demonstrate how pursuing practical (e.g.
        robotic) applications can provide insights of the core MFC
        technology in general.
      
      
      
      
      Biographical Information
      
      
      
      Ioannis
        A. Ieropoulos is the Theme Leader for Bioenergy &
        Self-Sustainable Systems at the Bristol Robotics Laboratory and
        an EPSRC Career Acceleration Fellow. He produced EcoBots I and
        II for his PhD, and EcoBot-III as part of an EU FP-6 programme,
        which together are the world’s first examples of
        self-sustainable robots, utilising waste and biomass. For the
        last 10 years he has been working on autonomous robotics and
        further improving the MFC technology for the utilisation of
        waste into energy. Currently he leads the “Urine-tricity”
        project funded by the Bill & Melinda Gates Foundation as
        well as the “Decomposing robots” project funded by the
        Leverhulme Trust.